Hypermethylation of the hTERT promoter inhibits the expression of telomerase activity in normal oral fibroblasts and senescent normal oral keratinocytes

British Journal of Cancer

Volumn 89, Issue 8, 2003, Pages 1473-1478

  Shin, K H ^a   Kang, M K ^a   Dicterow, E ^a   Park, N H ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UCLA SCHOOL OF DENTISTRY   (United States)

Author keywords

Fibroblasts; hTERT; Hypermethylation; Keratinocytes; Senescence

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; LUCIFERASE; RNA DIRECTED DNA POLYMERASE; TELOMERASE;

ARTICLE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; ENZYME INHIBITION; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; KERATINOCYTE; MOUTH CANCER; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENESCENCE; TELOMERIC REPEAT AMPLIFICATION PROTOCOL;

CATALYTIC DOMAIN; CELL CULTURE TECHNIQUES; DNA METHYLATION; DNA-BINDING PROTEINS; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; KERATINOCYTES; MOUTH; PROMOTER REGIONS (GENETICS); TELOMERASE;

EID: 0242574736     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601291     Document Type: Article

References (32)

1. Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP (1998) Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 72: 141-196
2. Bechter OE, Eisterer W, Dlaska M, Kuhr T, Thaler J (2002) CpG island methylation of the hTERT promoter is associated with lower telomerase activity in B-cell lymphocytic leukemia. Exp Hematol 30: 26-33
3. Bender CM, Pao MM, Jones PA (1998) Inhibition of DNA methylation by 5-aza-2′-deoxycytidine suppresses the growth of human tumor cell lines. Cancer Res 58: 95-101
4. Cerezo A, Kalthoff H, Schuermann M, Schafer B, Boukamp P (2002) Dual regulation of telomerase activity through c-Myc-dependent inhibition and alternative splicing of hTERT. J Cell Sci 115: 1305-1312
5. Cong YS, Wen J, Bacchetti S (1999) The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter. Hum Mol Genet 8: 137-142
6. Dessain SK, Yu H-Y, Reddel RR, Beijersbergen RL, Weinberg RA (2000) Methylation of the human telomerase gene CpG island. Cancer Res 60: 537-541
7. Devereux TR, Horikawa I, Anna CH, Annab LA, Afshari CA, Barrett JC (1999) DNA methylation analysis of the promoter region of the human telomerase reverse transcriptase (hTERT) gene. Cancer Res 59: 6087-6090
8. Ding Z, Green AG, Yang X, Chernenko G, Tang SC, Pater A (2002) Retinoic acid inhibits telomerase activity and downregulates expression but does not affect splicing of hTERT: correlation with cell growth rate inhibition in an in vitro cervical carcinogenesis/multidrug-resistance model. Exp Cell Res 272: 185-191
9. Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, Adams RR, Chang E, Allsopp RC, Yu F, Le S, West MD, Harley CB, Andrews W, Greider CW, Villeponteau B (1995) The RNA component of human telomerase. Science 269: 1236-1241
10. Guilleret I, Yan P, Grange F, Braunschweig R, Bosman FT, Benhattar J (2002) Hypermethylation of the human telomerase catalytic subunit (hTERT) gene correlates with telomerase activity. Int J Cancer 101: 335-341
11. Harle-Bachor C, Boukamp P (1996) Telomerase activity in the regenerative basal layer of the epidermis inhuman skin and in immortal and carcinoma-derived skin keratinocytes. Proc Natl Acad Sci USA 93: 6476-6481
12. Harrington L, McPhail T, Mar V, Zhou W, Oulton R, Bass MB, Arruda I, Robinson MO (1997) A mammalian telomerase-associated protein. Science 275: 973-977
13. Herman JG (1999) Hypermethylation of tumor suppressor genes in cancer. Semin Cancer Biol 9: 359-367
14. Horikawa I, Cable PL, Afshari C, Barrett JC (1999) Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene. Cancer Res 59: 826-830
15. Imamura T, Ohgane J, Ito S, Ogawa T, Hattori N, Tanaka S, Shiota K (2001) CpG island of rat sphingosine kinase-1 gene: tissue-dependent DNA methylation status and multiple alternative first exons. Genomics 76: 117-125
16. Kang MK, Bibb C, Baluda MA, Rey O, Park N-H (2000) In vitro replication and differentiation of normal human oral keratinocytes. Exp Cell Res 258: 288-297
17. Kang MK, Guo W, Park N-H (1998) Replicative senescence of normal human oral keratinocytes is associated with the loss of telomerase activity without shortening of telomeres. Cell Growth Differ 9: 85-95
18. Kang MK, Swee J, Kim RH, Baluda MA, Park NH (2002) The telomeric length and heterogeneity decrease with age in normal human oral keratinocytes. Mech Ageing Dev 123: 585-592
19. Kilian A, Bowtell DD, Abud HE, Hime GR, Venter DJ, Keese PK, Duncan EL, Reddel RR, Jefferson RA (1997) Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum Mol Genet 6: 2011-2019
20. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, Coviello GM, Wright WE, Weinrich SL, Shay JW (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015
21. Liu K, Schoonmaker MM, Levine BL, June CH, Hodes RJ, Weng NP (1999) Constitutive and regulated expression of telomerase reverse transcriptase (hTERT) in human lymphocytes. Proc Natl Acad Sci USA 96: 5147-5152
22. Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD, Ziaugra L, Beijersbergen RL, Davidoff MJ, Liu Q, Bacchetti S, Haber DA, Weinberg RA (1997) hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90: 785-795
23. Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, Lingner J, Harley CB, Cech TR (1997) Telomerase catalytic subunit homologs from fission yeast and human. Science 277: 955-959
24. Poole JC, Andrews LG, Tollefsbol TO (2001) Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT). Gene 269: 1-12
25. Shay J, Bacchetti S (1997) A survey of telomerase activity in human cancer. Eur J Cancer 33: 787-791
26. Shiota K, Kogo Y, Ohgane J, Imamura T, Urano A, Nishino K, Tanaka S, Hattori N (2002) Epigenetic marks by DNA methylation specific to stem, germ and somatic cells in mice. Genes Cells 1: 961-969
27. Takakura M, Kyo S, Kanaya T, Hirano H, Takeda J, Yutsudo M, Inoue M (1999) Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Res 59: 551-557
28. Ulaner GA, Hu JF, Vu TH, Giudice LC, Hoffman AR (1998) Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts. Cancer Res 58: 4168-4172
29. Ulaner GA, Hu JF, Vu TH, Oruganti H, Giudice LC, Hoffman AR (2000) Regulation of telomerase by alternate splicing of human telomerase reverse transcriptase (hTERT) in normal and neoplastic ovary, endometrium and myometrium. Int J Cancer 85: 330-335
30. Wick M, Zubov D, Hagen G (1999) Genomic organization and promoter characterization of the gene encoding the human telomerase reverse transcriptase (hTERT). Gene 232: 97-106
31. Yi X, Shay JW, Wright WE (2001) Quantitation of telomerase components and hTERT mRNA splicing patterns in immortal human cells. Nucleic Acids Res 29: 4818-4825
32. Zingg IM, Jones PA (1997) Genetic and epigenetic aspects of DNA methylation on genome expression, evolution, mutation and carcinogenesis. Carcinogenesis 18: 869-882